Ex vivo effects of flavonoïds extracted from Artemisia herba alba on cytokines and nitric oxide production in Algerian patients with Adamantiades-Behçet's disease

Journal of Inflammation

Volumn 8, Issue , 2011, Pages

  Messaoudene, Djamel ^a,b   Belguendouz, Houda ^a   Ahmedi, Mohamed ^a   Benabdekader, Tarek ^b   Otmani, Fifi ^c   Terahi, Malika ^c   Youinou, Pierre ^d   Touil Boukoffa, Chafia ^a  

^a UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^b UNIVERSITY OF BOUMERDES   (Algeria)

^c CHU Mustapha   (Algeria)

^d BREST UNIVERSITY HOSPITAL   (France)

Author keywords

Adamantiades Beh et's disease; Artemisia herba alba; Flavonods; IL 12; IL 4; Immunomodulation; nitric oxide

Indexed keywords

CYTOKINE; FLAVONOID; INTERLEUKIN 12; INTERLEUKIN 4; NITRIC OXIDE;

ADAMANTIADES BEHCET DISEASE; ADULT; ALGERIA; ARTEMISIA; ARTEMISIA HERBA ALBA; ARTICLE; BEHCET DISEASE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VIVO STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN MODIFICATION; PROTEIN SYNTHESIS INHIBITION; TH1 CELL; TH2 CELL; UPREGULATION;

ARTEMISIA HERBA-ALBA;

EID: 81355138185     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-8-35     Document Type: Article

References (50)

1. Pathophysiology of Behçet's disease. Amoura Z, Guillaume M, Caillat-Zucman S, Wechsler B, Piette JC, La revue de medicine interne 2006 27 843 853 10.1016/j.revmed.2006.02.014 (Pubitemid 44754845)
2. Behcet's syndrome: disease manifestations, management, and advances in treatment. Yazici H, Fresko I, Yurdakul S, Nature clinical practice 2007 3 148 155 10.1038/ncprheum0436 17334337 (Pubitemid 46416263)
3. Cytokine profile in Behçet's disease patients. Hamzaoui K, Hamzaoul A, Guemira F, Bessioul M, Hamza M, Ayed K, Scand J Rheumatol 2002 31 205 210 10.1080/030097402320318387 12369651 (Pubitemid 34971876)
4. Increased frequencies of interleukin-2- and interferon-gamma producing T cells in patients with active Behçet's disease. Sugi-Ikai N, Nakazawa M, Nakamura S, Ohno S, Minami M, Invest Ophthalmol Vis Sci 1998 39 996 1004 9579479 (Pubitemid 28196685)
5. Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases. Saruhan-Direskeneli G, Yentür SP, Akman-Demir G, Iik N, Serdarolu P, J Neuroimmunol 2003 145 127 134 10.1016/j.jneuroim.2003.08.040 14644038 (Pubitemid 37485973)
6. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behçet's disease. Imamura Y, Kurokawa MS, Yoshikawa H, Nara K, Takada E, Masuda C, Tsukikawa S, Ozaki S, Matsuda T, Suzuki N, Clin Exp Immunol 2005 139 371 378 10.1111/j.1365-2249.2005.02695.x 15654837 (Pubitemid 40222856)
7. Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Frassanito MA, Dammacco R, Cafforio P, Dammacco F, Arthritis Rheum 1999 42 1967 1974 10.1002/1529- 0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z 10513814 (Pubitemid 30257764)
8. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern. Raziuddin S, Al-Dalaan A, Bahabri S, Siraj AK, Al-Sedairy S, J Rheumatol 1998 25 329 33 9489829
9. The Chemistry of DNA damage from nitric oxide and peroxynitrite. Buney S, Caufield JL, Niles JC, Wishnok JS, Tannbaum SR, Mutation Res 1999 424 37 49 10.1016/S0027-5107(99)00006-8 10064848 (Pubitemid 29101606)
10. Protein modification elicited by oxidized low-density lipoprotein (LDL) in endothelial cells. Protection by (-)-epicatechin. Steffen Y, Jung T, Klotz LO, Schewe T, Grune T, Sies H, Free Radic Biol Med 2007 42 955 70 10.1016/j.freeradbiomed.2006.12.024 17349924 (Pubitemid 46356890)
11. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Beckman JS, Koppenol WH, Amer J Physiol 1996 271 1424 C1437 8944624
12. Nitric oxide: A mediator in rat tubular hypoxia/reoxygenation injury. Yu L, Gengro PE, Niedrberger M, Burk TJ, Schrier RW, Proceeding of the Natural Academy of Science USA 1994 91 1691 1695 10.1073/pnas.91.5.1691
13. Nitric oxide modulation by retinoic acid, IL-17A and TNF- in PBMC and colonic mucosa cultures from Algerian patients with inflammatory bowel disease. Rafa H, Abdelouaheb K, Belkhelfa M, Medjeber O, Saoula H, Zeriguine R, Nakmouche M, Touil-Boukoffa C, Cytokine 2010 52 17 34
14. Production des cytokines Th1/Th2 et du monoxyde d'azote au cours de l'uvéite Behçet et de l'uvéite idiopathique. Guenane H, Hartani D, Chachoua L, Lahlou-Boukoffa OS, Mazari F, Touil-Boukoffa C, J Fr Ophtalmol 2006 29 146 152 10.1016/S0181-5512(06)73762-7 16523155 (Pubitemid 43357239)
15. NO as a secretory product of mammalian cells. Nathan C, J FASEB 1992 6 3051 3064
16. Inhibition of nitric oxide synthase as a potential, therapeutic target. Hobbs AJ, Higgs A, Moncada S, Ann Res Pharmacol Toxicol 1999 39 191 220 10.1146/annurev.pharmtox.39.1.191 (Pubitemid 29222557)
17. Direct scavenging of nitric oxide by green tea. Nakagawa T, Yokozawa T, Food Chem Toxicol 2002 40 1745 1750 10.1016/S0278-6915(02)00169-2 12419687 (Pubitemid 35284144)
18. In vitro and in vivo inhibitory activities of rutin, wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E(2) production. Shen SC, Lee WR, Lin HY, Huang HC, Ko Ch, Yang LL, Chen YC, Eur J Pharmacol 2002 446 187 194 10.1016/S0014-2999(02)01792-2 12098601 (Pubitemid 34722573)
19. GC-MS analysis of Artemisia herba-alba Asso essential oils from Algeria. Vernin G, Merad O, Vernin GMF, Zamkotsian RM, Parkanyi C, Dev Food Sci 1995 3A 147 205
20. Eudesmanolides and other constituents from Atemisia herba alba. Ahmed AA, Abou El-Ela M, Jakupovic J, Seif El-Din AA, Sabri N, Phytochem 1990 29 3661 3663 10.1016/0031-9422(90)85297-S
21. Terpenoids and flavonoids from Artemisia species. Tang HQ, Hu J, Yang L, Tan RX, Planta Med 2000 66 391 393 10.1055/s-2000-8538 10865468 (Pubitemid 30346315)
22. Lignans and sesquiterpene lactones from Artemisia Sieversiana and Inula racemosa. Tan RX, Tang HQ, Hu J, Shuai B, Phytochem 1998 49 157 161 10.1016/S0031-9422(97)00889-3 (Pubitemid 28415030)
23. A Comprehensive Dictionary of Traditional Chinese Medicine. Jiangsu New Medicine College, Shanghai Science and Technology Press, Shanghai 1977 627
24. Ferula harmonis 'zallouh' and enhancing erectile function in rats: efficacy and toxicity study. El-Thaher TS, Matalka KZ, Taha HA, Badwan AA, Int J Impot Res 2001 13 247 251 10.1038/sj.ijir.3900706 11494083 (Pubitemid 32743607)
25. Phytoestrogens in health and disease. Davis SR, Dalais FS, Simpson ER, Murkies AL, Recent Prog Horm Res 1999 54 185 211 10548876 (Pubitemid 30074691)
26. Antifertility and hormonal properties of certain carotane sesquiterpenes of Ferula jaeschkeana. Singh MM, Agnihotri A, Garg SN, Agarwal SK, Gupta DN, Keshri G, Kamboj VP, Planta Med 1988 54 492 494 10.1055/s-2006-962526 3212073 (Pubitemid 19007989)
27. Flavonoid glycosides of Artemisia monosperma and A. herba alba. Saleh NAM, El- Negoumy SI, Abd-All MF, Abou- Zaid MM, Dellamonica G, Chopin J, Phytochem 1985 24 201 203 10.1016/S0031-9422(00)80845-6
28. Flavonoids of Artemisia judaica, A. monosperma and Artemisia herba-alba. Saleh NAM, El-Negoumy SI, Abou-Zaid MM, Phytochem 1987 26 3059 3064 10.1016/S0031-9422(00)84593-8
29. Review of the flavonoïds quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability and epidemiology. Erlund I, Nutr Res 2004 24 851 874 10.1016/j.nutres.2004.07.005 (Pubitemid 39600842)
30. The flavonoid quercetin inhibits proinflammatory cytokine (Tumor necrosis factor alpha) gene expression in normal peripheral mononuclear cells via modulation of the NF-B system. Nair MP, Mahajan S, Reynolds JL, Aalinkeel R, Nair H, Schwartz SA, Kandaswami C, Clin Vaccine Immunol 2006 13 319 328 10.1128/CVI.13.3.319-328.2006 16522772
31. Advances in flavonoids research since 1992. Harborne JB, Williams CA, Phytochem 2000 55 481 504 10.1016/S0031-9422(00)00235-1
32. Phenolic compounds: Evidence for inhibitory effects against obesity and their underlying molecular signalling mechanisms. Hsu CL, Yen GC, Mol Nutr Food Res 2008 52 53 61 10.1002/mnfr.200700393 18081207 (Pubitemid 351211802)
33. Flavonoids: Dietary occurrence and biochemical activity. Peterson J, Dwyer J, Nutrition Res 1998 18 1995 2018 10.1016/S0271-5317(98)00169-9 (Pubitemid 28543827)
34. Phenolic compounds from the leaves of Cyclocarya paliurus (Batal.) Iljinskaja and their inhibitory activity against PTP1B. Zhang J, Shen Q, Lu JC, Li JY, Liu WY, Yang JJ, Li J, Xiao K, Food Chem 2010 119 1491 1496 10.1016/j.foodchem.2009.09.031
35. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's disease, Lancet 1990 335 1078 1080 1970380
36. Plantes médicinales de la nouvelle Calédonie./2, Etude particulière de plantes dérivés polyphénoliques. Paris R, Nothis A, Plant Med Phytothérapie 1970 4 63 74 22070681
37. In Vitro Antihydatic Action of Gamma Interferon (IFN) is Dependent of Nitric Oxide (NO) pathway. Amri M, At Assa S, Belguendouz H, Mezioug D, Touil-Boukoffa C, J Interferon Cytokine Res 2007 22 781 787 (Pubitemid 47479862)
38. The favonoid baicalin inhibits superantigen-induced inflammatory cytokines and chemokines. Krakauer T, Li BQ, Young HA, FEBS Letters 2001 500 52 55 10.1016/S0014-5793(01)02584-4 11434925 (Pubitemid 32575317)
39. Interleukin 12 and its role in the generation of TH1 cells. Trinchieri G, Immunol Today 1993 14 335 338 10.1016/0167-5699(93)90230-I 8103338 (Pubitemid 23198164)
40. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Elenkov IJ, Chrousos GP, Trends Endocrinol Metab 1999 10 359 68 10.1016/S1043-2760(99)00188-5 10511695 (Pubitemid 29496010)
41. Increased serum nitric oxide production in patients with Behçet's disease: is it a new activity marker? Evereklioglu C, Turkoz Y, Er H, Inaloz HS, Ozbek E, Cekmen M, J Am Acad Dermatol 2002 46 50 54 10.1067/mjd.2002.118338 11756945 (Pubitemid 34073477)
42. Effet de la corticothérapie sur la production des interleukines 8, 12 et du monoxyde d'azote au cours des uvéites Behçet et idiopathique Belguendouz H, Messaoudene D, Hartani D, Chachoua L, Ahmedi ML, Lahmar-Belguendouz K, Lahlou-Boukoffa OS, Touil-Boukoffa C, J Fr Ophtalmol 2008 31 387 395 10.1016/S0181-5512(08)71433-5 18563038
43. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease. Evereklioglu C, Er H, Turkoz Y, Cekmen M, Mediators Inflamm 2002 11 87 93 10.1080/09629350220131935 12061429 (Pubitemid 34526411)
44. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behcet's disease: a pilot study. Duygulu F, Evereklioglu C, Calis M, Borlu M, Cekmen M, Ascioglu O, Clin Rheumatol 2005 24 324 30 10.1007/s10067-004-1015-3 15902528 (Pubitemid 41102427)
45. Aqueous humor nitric oxide levels in patients with Behçet disease. Yilmaz G, Sizmaz S, Yilmaz ED, Duman S, Aydin P, Retina 2002 22 330 5 10.1097/00006982-200206000-00012 12055467 (Pubitemid 36150598)
46. Interferon- and Nitric Oxide Production During Behçet Uveitis: Immunomodulatory Effect of Interleukin-10. Belguendouz H, Messaoudene D, Lahmar K, Ahmedi L, Medjeber O, Hartani D, Lahlou-Boukoffa O, Touil-Boukoffa C, J interferon Cytokine Res 2011 31 643 51 10.1089/jir.2010.0148 21510811
47. Inhibition of cytokine production by the traditional oriental medicine, 'Gamcho-Sasim-Tang' in mitogen-stimulated peripheral blood mononuclear cells from Adamantiades-Behçet's patients. Mi-Sun K, Hwan-Suck C, Jun-Gyoung L, Woon Ki L, Chung-Yeon H, Eon-Jeong L, Kwang-Ho C, Dac-Han W, Hyung-Min K, J Ethnopharmacol 2002 83 123/ 128 10.1016/S0378-8741(02)00221-0 (Pubitemid 36164735)
48. Combined treatment with colchicine and Herba Taraxaci (arazacum mongolicum Hand.-Mazz.) attenuates Behçet's disease-like symptoms in mice and influences the expressions of cytokines. Seonghyang S, Dongsik B, Seung Ihm L, Young Ae K, Eun-So L, Jee Yong H, Jang Hyun K, Suh Young C, Sungnack L, Interl Immunopharmacol 2003 3 713 721 10.1016/S1567-5769(03)00071-7 (Pubitemid 36577298)
49. IL-4 secreted from individual naive CD4+ T cells acts in an autocrine manner to induce Th2 differentiation. Noben-Trauth N, Hu-Li J, Paul WE, Eur J Immunol 2002 32 1428 33 10.1002/1521-4141(200205)32:5<1428::AID- IMMU1428>3.0.CO;2-0 11981831 (Pubitemid 34546271)
50. Anti-inflammatory activities of flavonoids isolated from Caesalpinia pulcherrima. Koteswara Rao Y, Fang SH, Tzeng YM, J Ethnopharmacol 2005 100 249 253 10.1016/j.jep.2005.02.039 15893896 (Pubitemid 41206619)